Edition: Global  
One News Page
“Probably the fastest-access news portal in the world”
> >

Living Cell Technologies maps timeline to clinical results from Parkinson's trial

Proactive Investors Wednesday, 8 November 2017 ()
Living Cell Technologies Ltd (ASX:LCT) is preparing some highly anticipated results from the NTCELL Parkinson's disease clinical trial, which are expected on Friday 10th November 2017. Shares in the company had been rising on the anticipation, recently hitting $0.28, but have lost some momentum and were changing hands at $0.205 at yesterday's close. Mid-year shares could have been snapped up around the $0.11 range. The ASX has this morning granted Living Cell a trading halt to prepare details from the trial. The halt will remain in place until the opening of trade on Monday 13th November 2017, or earlier if an announcement is made to the market.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 
Source: Wochit News - < > Embed

News video: Plasma Transfusions Show Promise As Alzheimer's Treatment

Plasma Transfusions Show Promise As Alzheimer's Treatment 00:47

Blood plasma transfusions achieved promising results as a treatment for Alzheimer's disease in a small clinical trial.

Recent related news

Living Cell Technologies in trading halt pending Parkinson's trial result

Living Cell Technologies in trading halt pending Parkinson's trial result
ASX-listed Kiwi biotech firm Living Cell Technologies is in a trading halt until tomorrow when it expects to announce the results of a clinical trial testing its...
New Zealand Herald - Business

International Stem Cell Corporation Announces Positive Interim Clinical Results for Parkinson's Disease Clinical Trial

CARLSBAD, CA--(Marketwired - Nov 13, 2017) - International Stem Cell Corporation (OTCQB: ISCO), a California-based clinical stage biotechnology company...
Marketwired - Press Releases

Living Cell faces slower road to commercialisation after trial needs more analysis

Living Cell faces slower road to commercialisation after trial needs more analysis
ASX-listed Kiwi biotech firm Living Cell Technologies won't seek provisional consent for its treatment for Parkinson's disease after the latest trial did not...
New Zealand Herald - Business

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for CD30-Positive Cutaneous T-Cell Lymphoma

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for CD30-Positive Cutaneous T-Cell Lymphoma
*Business Wire India*Takeda Pharmaceutical Company Limited (TSE: 4502) announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products...
Business Wire India - Press Releases

Immuron concludes promising fatty liver disease clinical study

Immuron Ltd (ASX:IMC, NASDAQ:IMRN) has concluded the phase II study of IMM‐124E for the treatment of NASH (non-alcoholic steatohepatitis), with the results...
Proactive Investors - Business

Living Cell Technologies' shares slump 85% at the open

Living Cell Technologies Ltd's (ASX:LCT) shares have plunged 85.4% to $0.03 on heavy volume in the first 15 minutes of trade, following the top-line results of...
Proactive Investors - Business

Summit Therapeutics to present pre-clinical data that reveals potential of DMD treatment

Drug discovery company Summit Therapeutics PLC (LON:SUMM) (NASDAQ: is set to present pre-clinical data from the University of Oxford highlighting the potential...
Proactive Investors - BusinessAlso reported by •Business Wire

Critical Outcome Technologies Announces Pharmacokinetic Data From Phase 1 Dose Escalation Portion of COTI-2 Trial in Gynecological Malignancies

*LONDON, ONTARIO and BOSTON, MASSACHUSETTS--(Marketwired - Nov. 15, 2017) -* *Critical Outcome Technologies Inc. (TSX VENTURE:COT)(OTCQB:COTQF)* *("COTI" or the...
Marketwired - Press Releases


You Might Like


Other recent news in Business

COMCAST is reportedly interested in buying 21st Century Fox (CMCSA, FOXA)Walmart jumps after beating on EARNINGS, raising guidance (WMT)
Cisco shoots to all-time high after saying it's set to grow REVENUE for the first time in 2 years (CSCO)WALMART helps to lift US markets
This LONDON borough is introducing a diesel charge for short stay parkingHouse Republicans pass $1.4tn TAX REFORM bill
NORWAY's state fund 'needs to ditch oil and gas investments'GOLDMAN SACHS want to help improve your 'financial wellness’ (GS)
Economy Hub: Is BITCOIN a real threat to the traditional currencies?This is why TIME INC's shares are soaring

Twitter

Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2017 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+